Nestmedic S.A. (WSE:NST)
Poland · Delayed Price · Currency is PLN 0.7200
+0.0080 (1.12%)
At close: Jul 24, 2026
Nestmedic Income Statement
Financials in millions PLN. Fiscal year is January - December.
Millions PLN. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1.15 | 0.85 | 0.97 | 1.55 | 1.87 | 0.65 | |
Revenue Growth (YoY) | 22.17% | -12.67% | -37.39% | -17.08% | 185.23% | 76.44% |
Cost of Revenue | 0.22 | 0.2 | 0.31 | 0.6 | 1.06 | 0.56 |
Gross Profit | 0.93 | 0.64 | 0.65 | 0.95 | 0.81 | 0.1 |
Selling, General & Admin | 4.15 | 3.67 | 4.65 | 6.43 | 6.63 | 3.65 |
Depreciation & Amortization Expenses | 0.94 | 0.95 | 1.05 | 0.55 | 0.38 | 0.19 |
Other Operating Expenses | 0.24 | 0.25 | 0.21 | 0.35 | 0.56 | 0.22 |
Total Operating Expenses | 5.33 | 4.87 | 5.91 | 7.33 | 7.56 | 4.06 |
Operating Income | -4.4 | -4.23 | -5.25 | -6.38 | -6.75 | -3.96 |
Interest Income | - | 0.01 | 0.03 | 0.03 | 0 | 0.05 |
Interest Expense | -0.18 | -0.25 | -0.22 | -0.41 | -0.31 | -0.37 |
Other Non-Operating Income (Expense) | 0.23 | -0.13 | 0.06 | -0 | 2.1 | 0.38 |
Total Non-Operating Income (Expense) | 0.05 | -0.37 | -0.13 | -0.39 | 1.8 | 0.06 |
Pretax Income | -4.35 | -4.6 | -5.38 | -6.77 | -4.95 | -3.91 |
Net Income | -4.35 | -4.6 | -5.38 | -6.77 | -4.95 | -3.91 |
Net Income to Common | -4.35 | -4.6 | -5.38 | -6.77 | -4.95 | -3.91 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 40 | 39 | 27 | 25 | 19 | 10 |
Shares Outstanding (Diluted) | 40 | 39 | 27 | 25 | 19 | 10 |
Shares Change (YoY) | 45.38% | 41.86% | 10.64% | 31.02% | 86.94% | 39.63% |
EPS (Basic) | -0.11 | -0.12 | -0.20 | -0.27 | -0.26 | -0.39 |
EPS (Diluted) | -0.11 | -0.12 | -0.20 | -0.27 | -0.26 | -0.39 |
EPS Growth | - | - | - | - | - | - |
Free Cash Flow | -8.19 | -7.27 | -4.31 | -6.67 | -8.21 | -7.8 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Per Share | -0.20 | -0.19 | -0.16 | -0.27 | -0.44 | -0.78 |
Gross Margin | 80.66% | 75.80% | 67.56% | 61.51% | 43.36% | 14.61% |
Operating Margin | -381.68% | -499.27% | -541.97% | -412.09% | -361.73% | -605.32% |
Profit Margin | -377.06% | -543.36% | -555.11% | -437.32% | -265.30% | -596.66% |
FCF Margin | -710.03% | -858.58% | -444.67% | -430.93% | -439.98% | -1192.29% |
EBITDA | -3.46 | -3.27 | -4.21 | -5.83 | -6.37 | -3.74 |
EBITDA Margin | -299.94% | -386.89% | -434.05% | -376.30% | -341.38% | -571.33% |
EBIT | -4.4 | -4.23 | -5.25 | -6.38 | -6.75 | -3.96 |
EBIT Margin | -381.68% | -499.27% | -541.97% | -412.09% | -361.73% | -605.32% |